At initial diagnosis, over 90% of PCa cases are androgen-dependent, making ADT in the reduction in circulating and tumor androgen levels and inhibition of androgen receptor (AR) signaling a good treatment option for PCa [6,7]. Here, AR is linked to neoplasm.